annual-report-FY2021

179 MAHINDRA & MAHINDRA LTD. INTEGRATED ANNUAL REPORT 2020-21 The Committee met thrice during the year under review on 6 th August, 2020, 9 th November, 2020 and 25 th March, 2021. The attendance at the Meetings was as under: Name of the Directors Committee Meetings 1 2 3 Held during tenure Attended % of attendance of a Member 6 th August, 2020 9 th November, 2020 25 th March, 2021 Dr. Pawan Goenka (Chairman)* 3 3 100% ^Dr. Anish Shah** 3 3 100% Mr. Rajesh Jejurikar** 3 3 100% Mr. T. N. Manoharan 3 3 100% Ms. Shikha Sharma 3 3 100% Mr. Vikram Singh Mehta*** 2 2 100% Mr. Haigreve Khaitan*** 2 1 50% Mr. Nadir B. Godrej**** 1 1 100% Mr. M. M. Murugappan**** 1 1 100% % of attendance at a Meeting 100% 100% 86% Risk Management Committee Meeting Attended through video conference O Leave of Absence * Ceased to be a Director and thereby Member and Chairman of the Committee with effect from 2 nd April, 2021. ** Appointed as Member of the Committee with effect from 1 st April, 2020. ^ Appointed as Chairman of the Committee with effect from 2 nd April, 2021. *** Appointed as Member of the Committee with effect from 8 th August, 2020. **** Ceased to be a Director and thereby Member of the Committee with effect from 8 th August, 2020. N.A. N.A. O N.A. N.A. N.A. N.A. RISK MANAGEMENT COMMITTEE REPORT FOR THE YEAR ENDED 31 ST MARCH, 2021 Activities of the Committee during the year Frequency Reviewed and approved the Enterprise Risk Management Framework of the Company P Reviewed assessment and mitigation of risks arising due to COVID-19, covering manufacturing constraints and supply chain disruptions, macro impact, short term and medium term impact P Reviewed the Risk Certificate covering risk management measures and controls and made recommendation to the Audit Committee and the Board P Monitored and reviewed Risk Management Plan including Cyber Security, Geopolitical Risks, and Related Risks and made recommendation to the Audit Committee and the Board P Reviewed the Risk Management Report, Risk Mitigation Measures as prescribed under the Risk Management Policy alongwith Extreme Risks their impact, likelihood and exposure and presented the same to the Audit Committee and the Board P Reviewed the risks for the financial year and presented the same to the Audit Committee and the Board A / P Frequency A Annually P Periodically F. Research & Development Committee (A voluntary initiative of your Company - wound-up with effect 8 th August, 2020) The Research & Development (“R&D”) Committee, which was constituted by the Board in 1998, provided direction on the R&D mission and strategy and key R&D and technology issues. The Committee reviewed and made recommendations on the skills and competencies required and the structure and the process needed to ensure that the R&D initiatives result in products that are in keeping with the business needs. Mr. M. M. Murugappan was the Chairman of the Committee. Mr. Anand G. Mahindra, Dr. Pawan Goenka and Mr. Nadir B. Godrej were the other Members of the Committee. The Committee met once during the year under review on 11 th June, 2020 which was attended by all the Members.